Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs SUMATRIPTAN: Safety Overview

Metric RIZATRIPTAN SUMATRIPTAN
Total FAERS Reports 2,896 17,442
Deaths Reported 68 305
Death Rate 2.3% 1.7%
Hospitalizations 479 1,580
Average Patient Age 44.6 yrs 45.7 yrs
% Female Patients 77.2% 84.9%
FDA Approval Date Apr 14, 2023 Apr 14, 2014
Manufacturer Panacea Biotec Limited Sun Pharmaceutical Industries, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued